Fludarabine Injection Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Fludarabine

Pipeline

Phase 1/2: 2

Top Sponsors

Medical University of South Carolina1
Chinese PLA General Hospital1

Indications

Cancer2
Chronic Lymphocytic Leukemia1
B-Cell Non-Hodgkin Lymphoma1
Hematologic Malignancy1
Solid Tumor1

Other1 trial

Clinical Study of the Safety and Efficacy of QH101 Cell in Patients With Malignant Tumors.

Phase 1/2

Charleston, South Carolina1 trial

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Hollings Cancer Center at Medical University of South Carolina

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.